Hosted on MSN
ORMP: Upcoming Expected Milestones Include OraTech Spin-Off & IPO, Launch of Phase 3 Trial
Oramed Pharmaceuticals (NASDAQ:ORMP) formed a JV with Hefei Tianhui Biotech (HTIT), OraTech Pharmaceuticals, which is a strategic initiative to move its assets forward. The JV partners recently made ...
Key Highlights – expected completion in YR 2025: I am happy to take this opportunity to provide our shareholders with an overview of our key accomplishments and outline our future direction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results